United States · FDA National Drug Code directory
XIGDUO XR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-6280_d3afc286-b96b-4fbd-b4bd-486a3f24e2f4
- Product NDC
- 0310-6280
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- dapagliflozin and metformin hydrochloride
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20141029
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPAGLIFLOZIN PROPANEDIOL — 10 mg/1
- METFORMIN HYDROCHLORIDE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0310-6280-30) · 0310-6280-30
- 1 BLISTER PACK in 1 CARTON (0310-6280-95) / 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 0310-6280-95
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →